Journal of Cancer Research and Therapeutics Close
 

Figure 3: Dose delivered to GTV and high risk "Avoidance Volume" (AV) with FSRS (30 Gy/5 fractions) in each patient. (a): Dose delivered to 95% volume of GTV (D95%) with DCA and RA in different patients. (b): Mean dose delivered to high risk "AV" with DCA and RA in the same patients. Mean dose to 'AV' was significantly less ( P−0.0001) with RA as compared with DCA in all the patients.

Figure 3: Dose delivered to GTV and high risk P−0.0001) with RA as compared with DCA in all the patients.">